TAMPA, Fla., Jan. 30, 2012 /PRNewswire/ -- rED Cap™, the proprietary, web-based clinical trial data management software developed by BioStat International, Inc. (BSI), recently received trademark status.

This distinction follows the October 2011 rollout of rED Cap™ during the BioFlorida Annual Conference.

Thanks to its intuitive navigation, and its usage-based, zero-licensing pricing model, rED Cap™ has received strong accolades in its first few months of release.

For multi-site clinical research trials, pharmaceutical research, development and marketing, and medical observational studies, rED Cap™ provides a comprehensive Web-based data management solution to collect and store data, all in a secure environment (rED Cap™ meets compliance requirements for both HIPAA and CFR21 Part 11).

To support quality research, rED Cap™ also features a customizable electronic case report form, flexible workflow, dynamic reporting and data status, and powerful data validation capability. BSI data management CRO service –offered with each rED Cap™ study – provides assistance to the research team in efficient project management, and experienced data analysis for meeting study objectives.

To find out how rED Cap™ can help your organization achieve its research goals, please contact Maureen Lyden at 813-979-1619 or mlyden@biostatinc.com.

About BioStat International, Inc.

BioStat International, Inc., is a contract research organization designed to meet the needs of device and pharmaceutical companies by providing a full range of product development services. Since its founding in 1994, BSI has delivered quality biostatistical and data management services and has expanded into project management, clinical monitoring, and medical writing. Its sincere devotion to quality, personal attention, support and commitment has made BSI a client-favorite CRO. www.biostatinc.com

 

SOURCE BioStat International, Inc.

Back to top

RELATED LINKS
http://www.biostatinc.com